ES544075A0 - Procedimiento para preparar una dispersion solida de una dishidropiridina farmacologicamente activa en una matriz cristalina como vehiculo. - Google Patents

Procedimiento para preparar una dispersion solida de una dishidropiridina farmacologicamente activa en una matriz cristalina como vehiculo.

Info

Publication number
ES544075A0
ES544075A0 ES544075A ES544075A ES544075A0 ES 544075 A0 ES544075 A0 ES 544075A0 ES 544075 A ES544075 A ES 544075A ES 544075 A ES544075 A ES 544075A ES 544075 A0 ES544075 A0 ES 544075A0
Authority
ES
Spain
Prior art keywords
dishydropyridine
preparing
procedure
vehicle
pharmacologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES544075A
Other languages
English (en)
Other versions
ES8702141A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES544075A0 publication Critical patent/ES544075A0/es
Publication of ES8702141A1 publication Critical patent/ES8702141A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES544075A 1984-06-14 1985-06-12 Procedimiento para preparar una dispersion solida de una dishidropiridina farmacologicamente activa en una matriz cristalina como vehiculo. Expired ES8702141A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (2)

Publication Number Publication Date
ES544075A0 true ES544075A0 (es) 1987-01-01
ES8702141A1 ES8702141A1 (es) 1987-01-01

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
ES544075A Expired ES8702141A1 (es) 1984-06-14 1985-06-12 Procedimiento para preparar una dispersion solida de una dishidropiridina farmacologicamente activa en una matriz cristalina como vehiculo.

Country Status (21)

Country Link
AT (1) AT391806B (es)
AU (2) AU587190B2 (es)
BE (1) BE902626A (es)
CA (1) CA1264441A (es)
CY (1) CY1635A (es)
DE (1) DE3520184C2 (es)
DK (1) DK167649B1 (es)
ES (1) ES8702141A1 (es)
FR (1) FR2565822B1 (es)
GB (3) GB2160100B (es)
GR (1) GR851430B (es)
HK (1) HK25192A (es)
HU (1) HU198844B (es)
IE (1) IE58834B1 (es)
IL (1) IL75490A0 (es)
IT (1) IT1200080B (es)
LU (1) LU85946A1 (es)
NL (1) NL194389C (es)
NZ (1) NZ212390A (es)
PT (1) PT80635B (es)
SE (1) SE504583C2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0406315B1 (en) * 1988-03-24 1992-11-11 Bukh Meditec A/S Controlled release composition
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
JP3148256B2 (ja) 1996-07-08 2001-03-19 エドワード メンデル カンパニー．，インコーポレーテッド 高用量難溶性薬物用持続放出マトリックス
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
EP1189599A2 (en) * 1999-06-11 2002-03-27 Eli Lilly And Company Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
ES2262528T3 (es) * 1999-08-04 2006-12-01 Astellas Pharma Inc. Composiciones medicinales estables para administracion oral que utilizan oxidos de hierro.
HK1042427A1 (zh) 1999-09-30 2002-08-16 Penwest Pharmaceuticals Co. 用於高溶度药物的持续释放基质方法
EP1368006B1 (en) * 2001-02-13 2006-05-03 AstraZeneca AB Novel modified released formulation
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (de) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Herstellung von Dosierungsformen mit einer festen Dispersion eines mikrokristallinen Wirkstoffs
US20100210792A1 (en) 2006-12-05 2010-08-19 David Taft Drug delivery
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
CA2734646C (en) * 2008-08-20 2016-06-28 James W. Mcginity Hot-melt extrusion of modified release multi-particulates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (de) * 1967-11-17 1971-03-25 Beiersdorf Ag Verfahren zur Herstellung von Arzneimitteln mit verzoegerter Wirkstoffabgabe in Form von Kapseln
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
DE2549740A1 (de) * 1975-11-17 1977-05-18 Sandoz Ag Neue galenische formen und verfahren zu deren herstellung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
SE442265B (sv) * 1978-12-21 1985-12-16 Sandoz Ag Fast, enteral-overdragen komposition i enhetsform for oral tillforsel innehallande en ergotalkaloid
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung

Also Published As

Publication number Publication date
NL194389C (nl) 2002-03-04
GB2196852B (en) 1989-05-17
NL8501578A (nl) 1986-01-02
GB2160100B (en) 1989-06-01
ATA174885A (de) 1990-06-15
CY1635A (en) 1992-11-06
DE3520184C2 (de) 1997-03-13
IE58834B1 (en) 1993-11-17
HK25192A (en) 1992-04-10
PT80635A (en) 1985-07-01
AU587190B2 (en) 1989-08-10
GB2196851B (en) 1989-06-07
IT1200080B (it) 1989-01-05
DK264785A (da) 1985-12-15
DE3520184A1 (de) 1985-12-19
AU4454389A (en) 1990-03-22
AT391806B (de) 1990-12-10
IE851460L (en) 1985-12-14
GB2196851A (en) 1988-05-11
GB8727055D0 (en) 1987-12-23
GR851430B (es) 1985-11-25
GB8514855D0 (en) 1985-07-17
ES8702141A1 (es) 1987-01-01
FR2565822B1 (fr) 1989-02-17
DK264785D0 (da) 1985-06-12
HU198844B (en) 1989-12-28
BE902626A (fr) 1985-12-10
AU4348685A (en) 1985-12-19
NL194389B (nl) 2001-11-01
SE8502950L (sv) 1985-12-15
FR2565822A1 (fr) 1985-12-20
GB8727056D0 (en) 1987-12-23
GB2160100A (en) 1985-12-18
DK167649B1 (da) 1993-12-06
NZ212390A (en) 1992-02-25
LU85946A1 (fr) 1986-01-24
PT80635B (pt) 1987-10-20
IT8548210A0 (it) 1985-06-13
HUT40918A (en) 1987-03-30
GB2196852A (en) 1988-05-11
IL75490A0 (en) 1985-10-31
SE8502950D0 (sv) 1985-06-13
SE504583C2 (sv) 1997-03-10
CA1264441A (en) 1990-01-16

Similar Documents

Publication Publication Date Title
ES541503A0 (es) Un metodo para preparar una forma de dosificacion unitaria solida, terapeuticamente activa
ES494274A0 (es) Procedimiento para la obtencion de una tableta divisible concesion controlada y retardada de la sustancia activa
ES541513A0 (es) Procedimiento para la obtencion de comprimidos de sustancia activa farmaceutica, de rapida desintegracion
ES511169A0 (es) Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos
ES557677A0 (es) Un procedimiento para preparar una proteina hibrida fibrinoliticamente activa.
NO884068D0 (no) Fremgangsmaate for aa uklebriggjoere fleksografiske fotopolymertrykkplater.
FI883050L (fi) Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
AU2717184A (en) Matrix composition for transdermal therapeutic system
DE3782394D1 (de) Immobilisiertes, physiologisch aktives material.
ES541629A0 (es) Procedimiento para preparar una nueva matriz a base de cola-geno
MX163193B (es) Mejoras en neumatico para tractor
PT86831A (pt) Process for preparing sustained release matrix formulations
CA1027105A (en) Powered outrigger beams having stabilizing spacer pad means
MX12038A (es) Composicion de uretano para fabricar volantes de direccion.
IT8467584A0 (it) Procedimento per rendere incombustibile un materiale sintetico vacuola to in foglio particolarmente una pelle sintetica
AU513669B2 (en) Manufacturing prestressed construction elements ina long mould bed
ES548544A0 (es) Procedimiento para preparar aislar y purificar un polipeptido activo como antibiotico.
ES533422A0 (es) Procedimiento para preparar celulas de cultivo en suspension de plantas de girasol.
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
HUT49563A (en) Process for producing optically active hydroxy-benzyl-amin derivatives, optically active amine-boron compounds containing them, and process for producing other optically active compounds with utilizing former optically active amine-boron compounds
NO890356L (no) Fremgangsmaate til aa utfoere vei- og markkonstruksjoner.
AU3447589A (en) Process for manufacture of plates, especially for construction use
FR2471291B1 (fr) Roue a structure composite, notamment pour automobiles
ES538040A0 (es) Procedimiento para preparar compuesto de adicion apropiados como agentes dispersantes.
ES548499A0 (es) Procedimiento para preparar una torta prensada acuosa, con- centrada en alto grado, de un material solido

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20061107